Our findings are consistent with trials showing BCG vaccination decreased disease activity and prevented progression of brain lesions in advanced multiple sclerosis, an autoimmune disease similarly sharing autoreactive T cells vulnerable to TNF-triggered cell death [26], [27]. This evidence concerns the gene TNF and multiple sclerosis.